The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery

Guus M.J. Bökkerink; Eelco JR de Graaf; Cornelis J.A. Punt; Irıs D. Nagtegaal; Heidi Rütten; Joost JME Nuyttens; Esther van Meerten; Pascal G. Doornebosch; Pieter J. Tanis; E. Derksen; Roy S. Dwarkasing; Corrie A.M. Marijnen; Annemieke Cats; Rob A.�E.�M. Tollenaar; Ignace H. J. T. de Hingh; H.J.T. Rutten; George P. van der Schelling; Albert J. ten Tije; Jeroen W. A. Leijtens; Guido Lammering; Geerard L. Beets; Theo Aufenacker; Apollo Pronk; Eric R. Manusama; Christiaan Hoff; Andreas J. A. Bremers; C. Verhoef; Johannes H.W. de Wilt

doi:10.1186/1471-2482-11-34

Abstract

The CARTS-study is one of the first prospective multicentre trials to investigate the role of a rectum saving treatment modality using chemoradiation therapy and local excision. The CARTS study is registered at clinicaltrials.gov (NCT01273051).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bökkerink et al. (2011) studied this question.

synapsesocial.com/papers/69d7cc55ba18484428d17eea https://doi.org/10.1186/1471-2482-11-34

View Full Paper

Ask AI

Bookmark

Share

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery

Abstract

Discussion

Cite This Study

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery

Abstract

Discussion

Cite This Study

Keep reading

Keep reading